Slovénie - slovène - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

gefitinib - filmsko obložena tableta - gefitinib 250 mg / 1 tableta - gefitinib

Union européenne - slovène - EMA (European Medicines Agency)

blueprint medicines (netherlands) b.v. - avapritinib - gastrointestinalni stromalni tumorji - druga zdravila z delovanjem na novotvorbe agenti, protein kinaza inhibitorji - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.

Union européenne - slovène - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - cistična fibroza - drugi proizvodi dihal - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.

Union européenne - slovène - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - trastuzumab deruxtecan - neoplazme dojke - antineoplastična sredstva - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.

Union européenne - slovène - EMA (European Medicines Agency)

bluebird bio (netherlands) b.v. - elivaldogene autotemcel - adrenoleukodystrophy - druga zdravila na živčnem sistemu - treatment of early cerebral adrenoleukodystrophy in patients less than 18 years of age, with an abcd1 genetic mutation, and for whom a human leukocyte antigen (hla) matched sibling haematopoietic stem cell donor is not available.

Slovénie - slovène - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

gefitinib - filmsko obložena tableta - gefitinib 250 mg / 1 tableta - gefitinib

Slovénie - slovène - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - escitalopram - orodisperzibilna tableta - escitalopram 5 mg / 1 tableta - escitalopram

Slovénie - slovène - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - escitalopram - orodisperzibilna tableta - escitalopram 10 mg / 1 tableta - escitalopram

Slovénie - slovène - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - escitalopram - orodisperzibilna tableta - escitalopram 20 mg / 1 tableta - escitalopram

Slovénie - slovène - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

genepharm (europe) trading ltd. - rivastigmin - kapsula, trda - rivastigmin 1,5 mg / 1 kapsula - rivastigmin